We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
- Authors
Baquero, Giselle A; Banchs, Javier E; Depalma, Sondra; Young, Sallie K; Penny-Peterson, Erica D; Samii, Soraya M; Wolbrette, Deborah L; Naccarelli, Gerald V; Gonzalez, Mario D
- Abstract
Patients with an implanted cardioverter defibrillator (ICD) and ventricular arrhythmias leading to ICD therapies have poor clinical outcomes and quality of life. Antiarrhythmic agents and catheter ablation are needed to control these arrhythmias. Dofetilide has only been approved for the treatment of atrial fibrillation. The role of dofetilide in the control of ventricular arrhythmias in patients with an ICD has not been established.
- Publication
Journal of cardiovascular electrophysiology, 2012, Vol 23, Issue 3, p296
- ISSN
1540-8167
- Publication type
Journal Article
- DOI
10.1111/j.1540-8167.2011.02183.x